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Aprendizagem da técnica inalatória em doentes com DPOC
Educational intervention and improvement of inhaler technique in COPD patients
Duarte-de-Araújo A.1,2,3, Teixeira P. 1,2, Hespanhol V. 4,5, Correia-de-Sousa J.1,2,6
 ARTIGO ORIGINAL | ORIGINAL ARTICLE
Objetivos: Avaliar se o ensino correto da técnica inalatória em doentes com DPOC a pode melhorar de uma forma 
sustentada e quais as caraterísticas dos inaladores e dos doentes que lhe estão associados.
Métodos: Doentes ≥ 40 anos com DPOC estável e diagnosticados de acordo com os critérios do GOLD foram 
avaliados em duas consultas médicas com um intervalo de dez a doze meses entre elas. Inicialmente foi aplicado 
um questionário demográfico e clínico e o Questionário de Crenças sobre Medicamentos. Na avaliação da técnica 
inalatória foi usada uma tabela de passos necessários para um correto uso dos inaladores e erros críticos. 
Posteriormente, a todos os participantes foi feito ensino e permitido treino com inaladores contendo placebo, até 
ao seu uso correto. Na segunda consulta foi feita uma reavaliação da técnica inalatória.
Resultados: Avaliamos 170 participantes realizando 266 manobras inalatórias com 10 diferentes inaladores. 
Registou-se uma melhoria no número de erros críticos em todos os tipos de inaladores, com significado estatístico 
naqueles que mais facilmente informavam o doente de que a inalação fora correta. A melhoria da técnica inalatória 
relacionou-se significativamente com o score do CAT. No subgrupo de doentes que melhoraram sua técnica 
inalatória, os homens tiveram uma média do score de necessidades do BMQ significativamente maior do que as 
mulheres.
Conclusões: Uma significativa melhoria da técnica inalatória foi observada nos inaladores que mais facilmente 
informam o doente sobre a correção da técnica inalatória. Os doentes mais sintomáticos mantiveram uma correta 
técnica inalatória de forma mais sustentada. As crenças sobre a necessidade do uso de inaladores estão associadas 
a uma melhor aprendizagem da técnica inalatória nos homens com DPOC. 
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 RESUMO
ABSTRACT
Objectives: To evaluate if the application of an educational intervention in COPD outpatients, regarding the correct 
use of the IDs, can improve inhalation technique in a sustained way, and to assess the inhalers and patient-related 
characteristics that are associated with some improvement of inhalation technique. 
Methods: Stable COPD outpatients diagnosed according to GOLD criteria were evaluated in two different medical 
visits. They were invited to demonstrate the use of their IDs, and inhaler technique was accessed by using check-
lists that include correct steps and critical errors. Posteriorly a correct teaching and training were given to all 
participants. After 10 to 12 months patients were invited for a second medical visit, and re-evaluation of inhaler 
technique was done. 
Results: We evaluated 170 participants performing 266 inhalation manoeuvers. There was an improvement on 
critical errors in all types of IDs with statistical significance in the IDs with an easy feed-back to the patient that 
a significant amount of medication has been inhaled. Improvement was significantly related to CAT score and in 
the subset of patients who improved their inhalation technique, males had an average BMQ Necessity score higher 
than females. 
Conclusions: Significantly improvement of inhalation technique was found in the group of IDs that provided an 
easy feed-back to patient that a significant amount of medication has been inhaled. More symptomatic patients 
learn better a correct inhaler technique than the less symptomatic ones. The beliefs about the need of medication 
are associated to inhaler technique improvement in male COPD patients. 
Keywords: COPD, Inhalation technique, Educational intervention, Sustained improvement.
48
Acta Farmacêutica Portuguesa, 2019, vol. 8, nº2
BACKgROUnD AnD OBjECTivES
Chronic Obstructive Pulmonary Disease 
(COPD) currently represents one of the 
most significant health problems at in-
ternational level, and its economic and 
social impact is still constantly increa- 
sing1. COPD is a chronic and incurable 
disease, but symptoms significantly im-
prove with therapy. Inhalers are the way 
used for an effective administration of 
medication, and it is of paramount im-
portance that patients use them correc- 
tly, to ensure that a full dose is received. 
However, inhalers misuse remains unac-
ceptably high2.  A large proportion of pa-
tients refer lack of effective training from 
their health care professionals (HCPs) 
and few are systematically checked in 
their medical visits, regarding the inha-
ler technique3. Face-to-face inhalers’ 
demonstration of the correct inhalation 
technique, verbal instructions, training 
the correct use and patients’ teach-back 
are probably the most effective me-
thods of teaching the correct inhalation 
technique (IT). As it can deteriorate over 
time, periodic evaluation and re-training 
is recommended4,5. It is not yet deter-
mined if improvement, after a single 
education intervention, is sustained 
over time6. The primary objective of this 
study was to evaluate if the application 
of an educational intervention in COPD 
outpatients, regarding the correct use of 
inhaler devices (IDs), can improve inha-
lation technique in a sustained way. The 
secondary objective was to assess the 
inhalers and patient-related characteris-
tics that are associated with a sustained 
improvement in IT. The variables under 
study, evaluated for potential associa- 
tion to IT improvement, were type of 
ID, age, gender, education level, income, 
Graffar Social Classification score, the 
Beliefs about Medicines Questionnaire 
(BMQ) Necessity score, smoking status, 
mMRC degree, CAT score, FEV1% and 
the number of COPD acute exacerba-
tions (ECOPD) in the previous year. 
MATERiAlS AnD METhODS
This is an interventional study conduc- 
ted in the outpatient respiratory care 
of Guimarães hospital. Stable COPD 
patients over 40 years, diagnosed ac-
cording to GOLD criteria and using 
inhaler devices were evaluated in two 
different medical visits, with a ten to 
twelve-months interval between visits. 
They were recruited consecutively and 
evaluated on a first medical visit be-
tween March 2016 and May 2017. No 
participants were enrolled in another 
different study, and all gave their writ-
ten informed consent. The study was 
approved by the Guimarães Hospital 
Ethics Committee, the Research Ethics 
Committee of Minho’ University and by 
the Portuguese Data Protection Agency. 
Refusal to participate and inability to 
understand and respond to simple ques-
tionnaires were the exclusion criteria. 
In the first visit, a survey of demogra- 
phic and clinical data, the Graffar Social 
Classification questionnaire, validated 
for use in Portuguese population7, and 
the Portuguese version of BMQ were ap-
plied8. The BMQ is an eleven-item ques-
tionnaire with a five-item Necessity scale 
and six-item Concern scale, assessing 
respectively the beliefs about the medi- 
cation’ necessity and concerns related 
to side-effects, dependence and toxicity 
of medication. Evaluation of symptoms 
was done using the Portuguese versions 
of the COPD Assessment Test (CAT) 
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and the Medical Research Council Dys-
pnea Questionnaire (mMRC). The num-
ber of ECOPD referred in the last year 
was recorded. We defined ECOPD ac-
cording to GOLD as an acute worsening 
of respiratory symptoms that results in 
additional therapy9, but also requiring 
an unplanned medical visit. All parti- 
cipants performed at least one spirome- 
try according to ERS/ATS criteria and 
referenced according to the Global Lung 
Function Initiative prediction equations 
(GLI 2012)10,11. Participants were invi- 
ted to demonstrate the use of their pres-
cribed ID, and demonstrations were 
done using inhalers containing placebo 
medications. Inhaler technique was ac-
cessed by using previous defined check-
lists of 5 steps for each ID (Table 1). 
They were developed according to the 
instructions provided by the manufac-
tures and to previous literature12,  and 
include essential steps and critical er-
rors. Errors considered critical are re-
lated to priming/loading or the inhala-
tion maneuver, and could substantially 
affect drug delivery to the lungs. These 
included lack of inhalation through the 
mouthpiece for all devices, slow and not 
forceful inhalation for dry powder inha-
lers (DPI) and rapid or forceful inhala-
tion for pressurized metered-dose inha-
lers (pMDI) or soft-mist inhalers (SMI). 
Critical errors device-dependent are lis-
ted in Table 2. 
Table 1. Check-list of 5 steps and errors for 
each ID
Table 2. Critical errors in different IDs
          
1- Correct priming or loading  
(Incorrect priming or loading were 
considered a critical error)
2- Exhalation before inhalation 
(No-exhalation before inhalation was 
not considered critical) 
3- Correct inhalation 
(Incorrect inhalation was considered 
a critical error)
4- Holding the breath a few seconds 
after inhalation (not required when 
using a spacer)
(Not holding the breath or exhalation 
through the mouthpiece was not con-
sidered critical)       
5- Finalization (cleaning the mouth-
piece, removing the used capsule af-
ter verifying that no powder remains, 
checking color changing in control 
window, closing ID and washing the 
mouth if necessary)
1- Aeroliser®, Breezhaler®, and Handiha-
ler®: failure to insert the capsule, failure 
to press and release buttons, powder re-
maining in the capsule after inhalation.
2- Diskus®: failure to open the cover, to 
slide the lever until it clicks, or not kee-
ping inhaler horizontally 
3- Ellipta®: failure to slide cover down 
until a click is heard or block air vent 
with fingers.
4- Genuair®: failure to remove the cap, to 
press and release the button until the 
control window has changed to green, 
not holding inhaler horizontally, and not 
changing control window to red after 
inhalation
5- pMDI: failure to remove cap, not shaking 
the inhaler (suspensions only), not hol-
ding the inhaler in the upright position, 
poorly synchronized hand actuation and 
inhalation, inhalation through the nose, 
actuation against teeth, lips or tongue.    
6- Respimat®:  lack of cartridge in the 
device, failure to open the cap, twisting 
the base or pressing the dose-release 
button, poorly synchronized hand actua-
tion and inhalation.
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Table 2. Critical errors in different IDs 
(cont.)
After this assessment, face-to-face de- 
monstration and training with placebo 
inhalers were given to all participants, 
until a correct use was achieved. Ten to 
twelve months later, participants were 
invited by mail for a second medical visit, 
and re-evaluation of inhalers’ technique 
was done by the same HCP using the 
same check-lists. Patients using different 
IDs were excluded. The difference in the 
number of critical errors between the two 
visits and the difference in total number 
of critical errors, because many patients 
used two or more inhalers, were defined 
as outcomes. Both outcomes were ex-
pressed as qualitative (equal number of 
critical errors, more errors - worsening of 
IT, less errors - improvement of IT). 
Statistical analysis was performed with 
SPSS Statistics for Windows software, 
version 23.0. Armonk, NY: IBM Corpo-
ration. For null hypothesis testing Chi-
Square test and Analysis of Variance with 
Covariant (ANCOVA) was performed. 
The level of statistical significance was 
set at p <0.05. 
Results
Sample characteristics
288 out 319 patients were invited for 
the second medical visit, but only 201 
agree to participate. From then, 31 were 
excluded because they were using diffe- 
rent IDs. We evaluated 170 participants 
(mean age = 66.8 years, 78.2% males) 
performing 266 inhalation manoeuvers. 
Ten different IDs were examined (Aero- 
liser®, Breezhaler®, Diskus®, Ellipta®, 
Genuair®, Handihaler®, pMDI, Res-
pimat®, Spiromax® and Turbuha ler®) in 
a total of 31 (11.7%) pMDI, 63 (23.7%) 
single-dose inhalers (sDPI) 136 (51.1%) 
multiple dose inhalers (mDPI) and 37 
(13.9%) SMI-Respimat®.  The main de-
mographic, clinical and functional charac-
teristics of patients are described in Table 
3.
Characteristics n = 170 
Mean age (years) 66.8 
Age ≥ 65 years 102 (60.0)
Male gender 133 (78.2)
Education level ≤ 3 school years 49 (28.8)
Education level ≤ 6 school years 152 (89.4)
Very low monthly income (< 530 
Euros)
119 (70.0)
Graffar social classification   4 + 5 105 (62.5)
mMRC grade ≥ 2 107 (62.9)
CAT score ≥ 10 100 (78.7)
ECOPD  ≥ 2 (last year) 70 (41.2)
Post-bronchodilator mean FEV1% 52.8
GOLD 2017 stage and classification (n; %):
I - 18 (10.6); II - 66 (38.8); III - 64 (37.6); IV - 22 
(12.9) 
A - 32 (18.8); B - 69 (40.6); C - 3 (1.8); D - 66 
(38.8)
Table 3. Demographic, clinical and functional 
characteristics of COPD patients
note: Data shown as mean or n (%).
Abbreviations:  mMRC, modified Research Coun-
cil Dyspnea Questionnaire; CAT, COPD Assess-
ment Test; ECOPD, chronic obstructive pulmo-
nary disease acute exacerbations; GOLD, Global 
Initiative for Chronic Obs- tructive Lung Disease.
7- Spiromax®: failure to hold the inhaler 
in upright position, failure to open 
mouthpiece cover until a click is heard 
or blocking air vent with fingers.
8- Turbuhaler®: failure to remove cover, 
to hold the inhaler upright when 
twisting the grip (tolerance ± 45º) 
until a click is heard.
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Tobacco smoking was the most common 
exposure identified. The mean tobac-
co exposure was 48.75 pack-years, and 
15.4% of subjects were current smokers. 
The distribution of patients according 
to GOLD 2017 stage and classification 
were 10.6%, 38.8%, 37.6% and 12.9% 
GOLD 1 to 4, and 18.8%, 40.6%, 1.8% 
and 36.8% GOLD A to D.
Results by iDs
In the second visit, a technique free from 
any errors was observed in 145 (54.5%) 
demonstrations, only 2.2% more than in 
the first evaluation. Errors were related 
to priming/loading (9.8%), lack of exha-
lation before inhalation (12.8%), inha-
lation manoeuvre (11.3%), lack of hol-
ding the breath after inhalation (27.1%) 
and incorrect finalisation (13.9%). After 
teaching the correct inhaler technique, 
critical errors were more often related 
to inhalation manoeuvres than to pri-
ming/loading. Holding the breath after 
inhalation was the step more difficult to 
be learned. Misuse related to priming/
loading and misuse related to inhalation 
manoeuvre were respectively higher 
in mDPI group (13.3%) and in pMDI 
(38.7%, p<0.001) group. Forgetting 
to hold the breath after inhalation was 
higher in sDPI group (38.1%, p=0.031). 
Table 4 presents the difference on errors 
related to the 5 steps for a correct inhal-
er technique in different types of inhaler 
devices. 
Errors related to:
                              priming 
/loading 
no-
exha-
lation  
inha-
lation  
hol-
ding 
the 
breath  
fina-
liza-
tion
mDPI
-3% -5.9% -8.1% +1.5% +0.8%
pMDI
-12.9% -22.4% -9.7%     -19.9% -19.4%
sDPI -12.7% -11.2% -7.9%     +6.4% +1.8%
Soft-
mist 
Inhaler
-8.1% -5.4% -13.5% -8.1% -8.1%
Table 4. Errors variation in visit 2 related to 
visit 1, by groups of inhaler devices.
Data are presented as the difference bet-
ween the percentage of errors in visit 2 
and visit 1. An improvement in num-
ber of critical errors was observed in 50 
(18.8%) and a worsening in 21 (7.9%) 
demonstrations. There was an observed 
improvement on critical errors in all 
types of IDs, with statistical significance 
in sDPI group. We found also a statis-
tically significant improvement in num-
ber of critical errors In the group of IDs 
(Aeroliser + Breezhaler + Handihaler 
+ Genuair) with an easy feed-back to 
the patient that a significant amount of 
medication has been inhaled (Table 5). 
Although some improvement in inha-
lation technique was observed in pMDI 
group, its misuse related to inhalation 
manoeuvre remains the more common 
reason for any inhaler misuse.
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Results by patients’ characteristics
A worsening in the total number of cri- 
tical errors was observed in 20 (8.8%) 
patients, and an improvement in 47 
(25.9%). Worsening or improvement 
were not significantly related to demo-
graphic characteristics as age (p=.262), 
gender (p=0.331), education level 
(p=.379), monthly income (p=0.965) 
Errors M1 Mcnemar test
No error Error Total        Worsened Improved P -value
mDPi
Error 
M2
No error    92  20 112 8.1% 14.7%
Error      11  13 24 0.150
Total  103 33 136
pMDi 
Error 
M2
No error  12 7 19 3.2% 22.6%
Error      1 11 12 0.070
Total  13 18 31
sDPi
Error 
M2
No error  48 10 58 1.6% 16.1%
Error      1 3 4 0.012
Total  49 13 62 8.1% 21.6%
Softm
Error 
M2
No error  23 8 31
Error      3 3 6 0.227
Total  26 11 37
sDPi + 
genuair  Error 
M2
No error  76 14 90 1.04% 14.6% 0.001
Error      1 5 6
Total  77 16 96
Table 5. Variation on critical errors in the different groups of inhaler devices.
note and abbreviations: Errors M1, Moment 1: first assessment; Errors M2, Moment 2: 
2nd assessment; mDPI, multiple-dose dry-powder inhalers; pMDI, pressurized inhalers; 
sDPI, single-dose dry-powder inhalers; Softm, soft-mist inhalers; errors shown as number of 
demonstrations; Worsened/Improved described as % of demonstrations.
or Graffar Social Classification score 
(p=0.144). They were also not related to 
airflow limitation (p=0.694). Improve-
ment was significantly related to CAT 
score (CAT<10: 22.2% worsened and 
22.2% improved inhalation technique; 
CAT≥10: 6% worsened and 25% im-
proved inhalation technique, p=0.037), 
but not to mMRC grade (p=0.474), 
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smoking history (p=0.752) or COPD 
acute exacerbations (p=0.472). Some 
change in inhaler technique after an 
education intervention was not signifi-
cantly related to BMQ Necessity score 
(p=0.719). However, in the subset of 
patients who improved their inhalation 
technique, male patients had an ave-
rage BMQ Necessity score significantly 
higher than females (mean BMQ Neces-
sity score were respectively 21.97 and 
17.88, p=0.017 – figure 1).
Figure 1. Necessity score by gender and 
difference in critical errors between the two 
visits.
DiSCUSSiOn
Some improvement in inhalation tech-
nique was achieved after a single edu-
cation intervention in all types of IDs, 
with statistical significance in the group 
of inhalers with an easy feed-back to 
the patient that a significant amount 
of medication has been inhaled. It ap-
pears that some devices’ attributes, 
by improving patients’ confidence on 
their use, improve the maintenance of 
a correct inhaler technique. A previous 
study referred that the same devices’ 
attributes leads to patients’ confidence 
and improves treatment adherence in 
COPD patients3. A significant number 
of papers explore the effects of educa-
tional intervention on frequency of 
inhaler errors. They vary in the dura-
tion of interventions, in the tools used 
to assess inhalers’ errors and in HCP in-
volved in the studies, but a significant 
improvement in inhalation technique is 
usually reported. In a recent systematic 
review on critical inhaler errors, 11 out 
of 21 studies exploring the relationship 
between previous inhaler instructions 
and frequency of inhaler errors, found 
a positive association between previ-
ous instructions and a better inhaler 
technique13.  In the present study, after 
teaching the inhaler technique, the mi- 
suse related to inhalation manoeuvre in 
the pMDI group remains the more com-
mon reason for any inhaler misuse. This 
is consistent with a previous study on 
seven different devices, where the worse 
technique was found in the pMDI group, 
with only 79% of patients using them 
correctly after education and training14. 
In our study, a significant rate of patients 
improved their inhalation technique; 
however, a worsening was also observed. 
The difference between technique im-
provement and worsening are related to 
the role played by the education inter-
vention, the maintenance of training by 
the daily use and the over-time deterio-
ration of inhalation technique. In COPD 
patients, mMRC and ECOPD are often 
examined outcomes related to inha-
ler technique. In a small experimental 
study, the number of ECOPD was si- 
gnificantly related to inhaler technique 
and to an education intervention, af-
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ter a 3 months follow-up15.  In a small 
cross-sectional study carried out in Por-
tuguese asthma and COPD patients, 
previous education on inhalation tech-
nique was associated with lower num-
ber of inhalers’ errors, however without 
impact on COPD stability16. In another 
small study published by the same Por-
tuguese group, an education interven-
tion regarding the inhalation technique 
was not related to clinical improvement 
in COPD patients, reevaluated 6 to 8 
months later17. In our study we failed to 
demonstrate any significant association 
between improvement of inhaler tech-
nique and many demographic, clinical 
or functional characteristics of COPD 
patients. Nonetheless, this lack of sta-
tistical significance gives clinical rele-
vance to the need of teaching the inha-
lation technique to all patients equally. 
In this sample the only significant as-
sociation was the positive association 
between symptoms and improvement 
of the inhaler technique. This can be 
a sample characteristic; however more 
symptomatic patients can be more mo-
tivated to learn how to use inhalers 
properly. We found that male patients 
who improve their inhalation technique 
seems to be more believers in the need 
of medication than women. We can thus 
assume that men, but not women, have 
to believe in the need for medication 
to learn better and improve inhalation 
technique. This information is new and 
need to be confirmed by other studies.
To the best of our knowledge, this is 
the largest study carried out in Portu-
guese population of COPD patients, 
concerning the sustained improvement 
of the inhalation technique after a sin-
gle educational intervention. However, 
this study was conducted in a single 
institution, with patients being treated 
by pulmonologists, and other possible 
education interventions, conducted by 
others HCPs, were uncontrolled. This 
may limit the generalisation of results 
to other populations18. We compared 
the number of critical errors before and 
after an education intervention. The 
definition of critical errors when using 
inhalers is of great importance, because 
they are likely to significantly decrease 
delivery of medication to the lungs, and 
thus impair health-related outcomes. 
However, there is currently a lack of con-
sensus on their definition13. Though it 
is based on previous medical literature, 
our definition of critical errors deserves 
discussion. Nonetheless, re-evaluation 
of inhalers’ technique was done using 
the same check-list of steps and errors 
of the previous visit, and re-evaluation 
was done by the same HTP, to avoid 
inter-observer variability. Some of this 
data can be useful in clinical practice in 
planning educations interventions rela- 
ted to inhaler devices.
COnClUSiOnS
A correct teaching of inhaler technique 
improves patients’ mastery to use inha-
lers in a sustained way. This data corrobo- 
rates the observations of other authors, 
and draws attention to the effectiveness 
of educational interventions. An easy 
feed-back that a significant amount of 
medication has been inhaled, presented 
by some inhaler devices, improve the 
maintenance of a correct inhaler tech-
nique. More symptomatic patients learn 
better a correct inhaler technique than 
the less symptomatic ones. The beliefs 
about the need of medication are asso-
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ciated with the maintenance of a correct 
mastery in male COPD patients. Clini-
cians must recognise that the inhaler 
device is as important as the drug itself, 
and this means not only prescribing the 
right device for a particular patient, but 
also training the patients in their correct 
use. 
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